Skip to main content
. Author manuscript; available in PMC: 2013 Jun 4.
Published in final edited form as: Mol Cancer Res. 2012 Jun 4;10(6):810–820. doi: 10.1158/1541-7786.MCR-11-0576

Table 1.

Percentage of tumors of myeloid and lymphoid origins from mice of indicated genotypes harboring the Eμ-N-RasG12D transgene, determined by immunogenotyping of the tumor cells and the type of infiltrated organs.

Tumor
origin
%
PRAK+/+
(n=15)
Myeloid* 80.0 %
Lymphoid 20.0 %
PRAK+/−
(n=33)
Myeloid 90.9 %
Lymphoid 9.1 %
PRAK−/−
(n=9)
Myeloid 77.8 %
Lymphoid 22.2 %
p53+/−
(n=22)
Myeloid 54.5 %
Lymphoid 45.5 %